These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34559198)

  • 1. Calcitonin receptor-like (CALCRL) is a marker of stemness and an independent predictor of outcome in pediatric AML.
    Angenendt L; Wöste M; Mikesch JH; Arteaga MF; Angenendt A; Sandmann S; Berdel WE; Lenz G; Dugas M; Meshinchi S; Schliemann C; Rössig C
    Blood Adv; 2021 Nov; 5(21):4413-4421. PubMed ID: 34559198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia.
    Angenendt L; Bormann E; Pabst C; Alla V; Görlich D; Braun L; Dohlich K; Schwöppe C; Bohlander SK; Arteaga MF; Wethmar K; Hartmann W; Angenendt A; Kessler T; Mesters RM; Stelljes M; Rothenberg-Thurley M; Spiekermann K; Hébert J; Sauvageau G; Valk PJM; Löwenberg B; Serve H; Müller-Tidow C; Lenz G; Wörmann BJ; Sauerland MC; Hiddemann W; Berdel WE; Krug U; Metzeler KH; Mikesch JH; Herold T; Schliemann C
    Leukemia; 2019 Dec; 33(12):2830-2841. PubMed ID: 31182782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of CALCRL-associated prognostic genes in acute myeloid leukemia.
    Huang Z; Zhang H; Xing C; Zhang L; Zhu H; Deng Z; Yin L; Dong E; Wang C; Peng H
    Gene; 2022 Jan; 809():146009. PubMed ID: 34655717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells.
    Larrue C; Guiraud N; Mouchel PL; Dubois M; Farge T; Gotanègre M; Bosc C; Saland E; Nicolau-Travers ML; Sabatier M; Serhan N; Sahal A; Boet E; Mouche S; Heydt Q; Aroua N; Stuani L; Kaoma T; Angenendt L; Mikesch JH; Schliemann C; Vergez F; Tamburini J; Récher C; Sarry JE
    Nat Commun; 2021 Jan; 12(1):422. PubMed ID: 33462236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CGRP Signaling via CALCRL Increases Chemotherapy Resistance and Stem Cell Properties in Acute Myeloid Leukemia.
    Gluexam T; Grandits AM; Schlerka A; Nguyen CH; Etzler J; Finkes T; Fuchs M; Scheid C; Heller G; Hackl H; Harrer N; Sill H; Koller E; Stoiber D; Sommergruber W; Wieser R
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31756985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CALCRL induces resistance to daunorubicin in acute myeloid leukemia cells through upregulation of XRCC5/TYK2/JAK1 pathway.
    Tang S; Li S; Shi X; Sheng L; Mu Q; Wang Y; Zhu H; Xu K; Zhou M; Xu Z; Wu A; Ouyang G
    Anticancer Drugs; 2024 Feb; 35(2):163-176. PubMed ID: 37948318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A.
    Grandits AM; Wieser R
    Exp Hematol; 2021 Jul; 99():1-11. PubMed ID: 34029637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia.
    Gentles AJ; Plevritis SK; Majeti R; Alizadeh AA
    JAMA; 2010 Dec; 304(24):2706-15. PubMed ID: 21177505
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Wang R; Li M; Bai Y; Jiao Y; Qi X
    J Oncol; 2022; 2022():3024360. PubMed ID: 35342399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying a novel 5-gene signature predicting clinical outcomes in acute myeloid leukemia.
    Sha K; Lu Y; Zhang P; Pei R; Shi X; Fan Z; Chen L
    Clin Transl Oncol; 2021 Mar; 23(3):648-656. PubMed ID: 32776271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of pretreatment telomere length as a prognostic marker in intermediate-risk acute myeloid leukemia.
    Gu R; Cao J; Wei S; Gong X; Wang Y; Mi Y; Zhang J; Qiu S; Rao Q; Wang M; Wei H; Wang J
    Int J Lab Hematol; 2021 Dec; 43(6):1510-1515. PubMed ID: 34288423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation pattern of calcitonin (CALCA) gene in pediatric acute leukemia.
    Ismail EA; El-Mogy MI; Mohamed DS; El-Farrash RA
    J Pediatr Hematol Oncol; 2011 Oct; 33(7):534-42. PubMed ID: 21423046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Wilms Tumor-1 (WT1) rs2234593 variant is a prognostic factor in normal karyotype acute myeloid leukemia.
    Niavarani A; Horswell S; Sadri R; Bonnet D
    Ann Hematol; 2016 Jan; 95(2):179-90. PubMed ID: 26499507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia.
    Ribeiro AF; Pratcorona M; Erpelinck-Verschueren C; Rockova V; Sanders M; Abbas S; Figueroa ME; Zeilemaker A; Melnick A; Löwenberg B; Valk PJ; Delwel R
    Blood; 2012 Jun; 119(24):5824-31. PubMed ID: 22490330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
    Lin X; Wang Z; Wang Y; Feng W
    Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT.
    Canaani J; Labopin M; Socié G; Nihtinen A; Huynh A; Cornelissen J; Deconinck E; Gedde-Dahl T; Forcade E; Chevallier P; Bourhis JH; Blaise D; Mohty M; Nagler A
    Am J Hematol; 2017 Jul; 92(7):653-659. PubMed ID: 28370339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission.
    Candoni A; De Marchi F; Zannier ME; Lazzarotto D; Filì C; Dubbini MV; Rabassi N; Toffoletti E; Lau BW; Fanin R
    Leuk Res; 2017 Dec; 63():22-27. PubMed ID: 29096332
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Bai H; Zhou M; Zeng M; Han L
    DNA Cell Biol; 2020 Apr; 39(4):700-708. PubMed ID: 32077754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin receptor family evolution and fishing for function using in silico promoter analysis.
    Martins R; Vieira FA; Power DM
    Gen Comp Endocrinol; 2014 Dec; 209():61-73. PubMed ID: 24815885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia.
    Chretien AS; Fauriat C; Orlanducci F; Rey J; Borg GB; Gautherot E; Granjeaud S; Demerle C; Hamel JF; Cerwenka A; von Strandmann EP; Ifrah N; Lacombe C; Cornillet-Lefebvre P; Delaunay J; Toubert A; Arnoulet C; Vey N; Olive D
    Oncotarget; 2017 Jul; 8(30):49548-49563. PubMed ID: 28548938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.